EUVIMEDSkopri EUVIMED
Crossref

Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia

Jianmin Chen iD, Juan Chen, Baozhu Feng, Meilian Ning, Wanhui Wu, Shiqi Zou

Biotechnology and Applied Biochemistry · 2025

DOI: 10.1002/bab.2690 ↗

At a glance

Journal article in Biotechnology and Applied Biochemistry, 2025. Written by Jianmin Chen and 5 co-authors. Institution: School of Pharmacy, Putian University, Fujian, China. Major MEDLINE topics: Resveratrol, Xanthine Oxidase, Hyperuricemia, Gout. Cited 8 times so far (Crossref); 52 references. Funded by: Research Projects of Putian University, National Natural Science Foundation of China, Science and Technology Bureau of Putian City.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Gout predominantly stems from hyperuricemia, precipitating the accumulation of urate crystals and consequent joint inflammation, swelling, and pain, thereby compromising the quality of life and presenting a formidable medical dilemma. Although conventional treatments like allopurinol and febuxostat target uric acid reduction via xanthine oxidase (XO) inhibition, they often entail adverse effects, prompting the exploration of safer alternatives. Resveratrol, a polyphenolic compound abundant in fruits and vegetables, has emerged as a potential XO inhibitor. However, its precise inhibitory mechanisms remain poorly understood. This study aims to comprehensively investigate resveratrol's XO inhibition through mechanistic insights, molecular docking simulations, animal model experiments, and biochemical analysis, contributing valuable insights to the development of novel therapeutics for hyperuricemia and gout.

Subjects

MeSH terms (MEDLINE)

ResveratrolXanthine OxidaseHyperuricemiaGoutEnzyme InhibitorsAnimalsMolecular Docking SimulationMiceHumansMale

Author keywords

allopurinolhyperuricemiaresveratroluric acidxanthine oxidase

Substances

ResveratrolXanthine OxidaseEnzyme Inhibitors

Authors and institutions

  • School of Pharmacy, Putian University, Fujian, China.
  • Key Laboratory of Pharmaceutical Analysis and Laboratory Medicine (Putian University), Fujian Province University, Fujian, China.

ORCID profiles: Jianmin Chen

Funding

  • Research Projects of Putian University
  • National Natural Science Foundation of China
  • Science and Technology Bureau of Putian City

Cite

APA

Chen, J., Chen, J., Feng, B., Ning, M., Wu, W., & Zou, S. (2025). Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2690

Vancouver

Chen J, Chen J, Feng B, Ning M, Wu W, Zou S. Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2690

BibTeX
@article{Chen2025,
  author = {Chen, Jianmin and Chen, Juan and Feng, Baozhu and Ning, Meilian and Wu, Wanhui and Zou, Shiqi},
  title = {Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2025},
  doi = {10.1002/bab.2690}
}
Start for free →